Yash A. Choksi
Vanderbilt University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yash A. Choksi.
The American Journal of Gastroenterology | 2013
David O. Francis; Jennifer A. Rymer; James C. Slaughter; Yash A. Choksi; Pawina Jiramongkolchai; Evbu Ogbeide; Christopher Tran; Marion Goutte; C. Gaelyn Garrett; David Hagaman; Michael F. Vaezi
OBJECTIVES:Extraesophageal symptoms are common manifestations of gastroesophageal reflux disease (GERD). Lack of a definitive diagnostic or treatment standards complicate management, which often leads to multiple specialty consultations, procedures, pharmaceuticals and diagnostic tests. The aim of this study was to determine the economic burden associated with extraesophageal reflux (EER).METHODS:Direct costs of evaluation were estimated for patients referred with symptoms attributed to EER between 2007 and 2011. Medicare payment for evaluation and management and pharmaceutical prices was used to calculate first year and overall costs of evaluating and treating extraesophageal symptoms attributed to reflux.RESULTS:Overall, 281 patients were studied (cough (50%), hoarseness (23%), globus/post-nasal drainage (15%), asthma (9%), and sore throat (3%)). Over a median (interquartile range) of 32 (16–46) months follow-up, patients had a mean (95% confidence interval) of 10.1 (9.4–10.9) consultations with specialists and underwent 6.4 (3–9) diagnostic procedures. Overall, the mean initial year direct cost was
Laryngoscope | 2009
David L. Zealear; Isamu Kunibe; Kenichiro Nomura; Cheryl R. Billante; Vikas Singh; Shan Huang; James Bekeny; Yash A. Choksi; Yasuaki Harabuchi; Akihiro Katada
5,438 per patient being evaluated for EER. Medical and non-medical components contributed
Laryngoscope | 2010
Kenichiro Nomura; Isamu Kunibe; Akihiro Katada; Charles T. Wright; Shan Huang; Yash A. Choksi; Rajshri Mainthia; Cheryl R. Billante; Yasuaki Harabuchi; David L. Zealear
5,154 and
Gut | 2013
Christopher S. Williams; Amber Bradley; Rupesh Chaturvedi; Kshipra Singh; Maria B. Piazuelo; Xi Chen; Elizabeth McDonough; David A. Schwartz; Caroline T. Brown; Margaret M. Allaman; Lori A. Coburn; Sara N. Horst; Dawn B. Beaulieu; Yash A. Choksi; Mary Kay Washington; Amanda D. Williams; Melissa A Fisher; Sandra S. Zinkel; Richard M. Peek; Keith T. Wilson; Scott W. Hiebert
283. Of the overall cost, 52% were attributable to the use of proton pump inhibitors. During the initial year, direct costs were 5.6 times higher than those reported for typical GERD (
Nature Reviews Gastroenterology & Hepatology | 2016
Rishi D. Naik; Yash A. Choksi; Michael F. Vaezi
971). A total of 54% of patients reported improvement of symptoms. Overall cost per improved patient was
The American Journal of Gastroenterology | 2017
Michael F. Vaezi; Yash A. Choksi
13,700.CONCLUSIONS:EER contributes substantially to health-care expenditures. In this cohort, the cost for initial years evaluation and treatment of EER symptoms was quintuple that of typical GERD. Prescription costs and, in particular, proton pump inhibitors were the single greatest contributor to the cost of EER management.
Alimentary Pharmacology & Therapeutics | 2018
Yash A. Choksi; James C. Slaughter; Rohit Sharda; Tina Higginbotham; Pooja Lal; Michael F. Vaezi
Bilateral stimulation of the posterior cricoarytenoid (PCA) muscles offers a physiologic approach to rehabilitate ventilation to a normal level in case of bilateral laryngeal paralysis. The objective was to evaluate the safety and efficacy of a new generation stimulator in restoring glottal opening, ventilation, and exercise tolerance.
Clinical Gastroenterology and Hepatology | 2017
Yash A. Choksi; Pooja Lal; James C. Slaughter; Rohit Sharda; Jacob Parnell; Tina Higginbotham; Michael F. Vaezi
Bilateral stimulation of posterior cricoarytenoid (PCA) muscles offers a physiologic approach to restore ventilation to a normal level in case of bilateral laryngeal paralysis. The objective of this study was to evaluate the long‐term efficacy and safety of a new generation stimulator in restoring ventilation and exercise tolerance.
Mucosal Immunology | 2018
Yash A. Choksi; Vishruth K. Reddy; Kshipra Singh; Caitlyn W. Barrett; Sarah P. Short; Bobak Parang; Cody Keating; Joshua J. Thompson; Thomas Verriere; Rachel E. Brown; M. Blanca Piazuelo; David M. Bader; M. Kay Washington; Mukul K. Mittal; Thomas Brand; Alain P. Gobert; Lori A. Coburn; Keith T. Wilson; Christopher S. Williams
Objective The myeloid translocation genes (MTGs) are transcriptional corepressors with both Mtg8−/− and Mtgr1−/− mice showing developmental and/or differentiation defects in the intestine. We sought to determine the role of MTG16 in intestinal integrity. Methods Baseline and stress induced colonic phenotypes were examined in Mtg16−/− mice. To unmask phenotypes, we treated Mtg16−/− mice with dextran sodium sulphate (DSS) or infected them with Citrobacter rodentium and the colons were examined for ulceration and for changes in proliferation, apoptosis and inflammation. Results Mtg16−/− mice have altered immune subsets, suggesting priming towards Th1 responses. Mtg16−/− mice developed increased weight loss, diarrhoea, mortality and histological colitis and there were increased innate (Gr1+, F4/80+, CD11c+ and MHCII+; CD11c+) and Th1 adaptive (CD4) immune cells in Mtg16−/− colons after DSS treatment. Additionally, there was increased apoptosis and a compensatory increased proliferation in Mtg16−/− colons. Compared with wild-type mice, Mtg16−/− mice exhibited increased colonic CD4;IFN-γ cells in vehicle-treated and DSS-treated mice. Adoptive transfer of wild-type marrow into Mtg16−/− recipients did not rescue the Mtg16−/− injury phenotype. Isolated colonic epithelial cells from DSS-treated Mtg16−/− mice exhibited increased KC (Cxcl1) mRNA expression when compared with wild-type mice. Mtg16−/− mice infected with C rodentium had more severe colitis and greater bacterial colonisation. Last, MTG16 mRNA levels were reduced in human ulcerative colitis versus normal colon tissues. Conclusions These observations indicate that MTG16 is critical for colonocyte survival and regeneration in response to intestinal injury and provide evidence that this transcriptional corepressor regulates inflammatory recruitment in response to injury.
Current Gastroenterology Reports | 2018
Caroline Barrett; Yash A. Choksi; Michael F. Vaezi
Obesity is a continuing epidemic with substantial associated morbidity and mortality. Owing to the limitations of lifestyle modifications and pharmacological options, bariatric surgery has come to the forefront as an efficient method of achieving sustained weight loss and decreasing overall mortality in comparison with nonsurgical interventions. The most frequently performed bariatric operations are either purely restrictive, such as laparoscopic adjustable gastric band (LAGB) and laparoscopic sleeve gastrectomy (LSG), or restrictive–malabsorptive, such as the Roux-en-Y gastric bypass (RYGB). Each operation results in weight loss, but can also have unintended effects on the health of the oesophagus. Specifically, operations might lead to oesophageal dilation or the development of GERD. LAGB is the best-studied procedure with notable evidence for postoperative worsening of GERD and pseudo-achalasia, which increases lower oesophageal pressure and causes aperistalsis. In some studies, LSG initiates not only a worsening of GERD, but also the formation of de novo GERD in patients without preoperative GERD symptoms. RYGB demonstrates the most profound evidence for improvement of GERD symptoms and preservation of oesophageal motility. Future high-quality studies will be required to better understand the interaction between bariatric surgery and oesophageal disease.